DUSP2 methylation is a candidate biomarker of outcome in head and neck cancer

BACKGROUND: Biomarkers predictive of response to chemoradiotherapy (CRT) regimens for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) are urgently required to identify patients in whom this approach is likely to be effective. TP53 mutations and epidermal growth factor (EGFR) overex...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ann Transl Med
Päätekijät: Lo Nigro, Cristiana, Vivenza, Daniela, Denaro, Nerina, Lattanzio, Laura, Fortunato, Mirella, Crook, Tim, Merlano, Marco Carlo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AME Publishing Company 2018
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6064804/
https://ncbi.nlm.nih.gov/pubmed/30094257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2018.06.39
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia